Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
- PMID: 11437745
- DOI: 10.1034/j.1600-0447.2001.00363.x
Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
Abstract
Objective: To assess care utilization, individual characteristics and clinical and functional outcomes for various modalities of professional care in people with DSM-III-R major depression.
Method: Psychiatric diagnoses were determined at baseline and 12-month follow-up in a representative sample (N = 7076) of the Dutch population, using the Composite International Diagnostic Interview (CIDI).
Results: A total of 45.3% of the 223 individuals with major depression received professional care in the 12 months between baseline and follow-up, and 42.6% of these were treated with antidepressant medication. Higher level of care was associated with clinical factors and functional limitations. Clinical outcomes were poorly correlated with functional outcomes. Mild to moderate effects in functional outcome were found for all care modalities.
Conclusion: Outcome of antidepressant treatment can be improved and such treatment should focus on the more severe forms of depression. Functional outcome assessment is recommended in addition to clinical assessment.
Similar articles
-
Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS).Acta Psychiatr Scand. 2001 Feb;103(2):122-30. doi: 10.1034/j.1600-0447.2001.103002122.x. Acta Psychiatr Scand. 2001. PMID: 11167315
-
Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS).J Affect Disord. 2002 Apr;68(2-3):203-13. doi: 10.1016/s0165-0327(00)00310-4. J Affect Disord. 2002. PMID: 12063148
-
Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).Acta Psychiatr Scand. 2004 Sep;110(3):208-14. doi: 10.1111/j.1600-0447.2004.00335.x. Acta Psychiatr Scand. 2004. PMID: 15283741
-
Levels of disability in major depression: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).J Affect Disord. 2003 Oct;77(1):53-64. doi: 10.1016/s0165-0327(02)00099-x. J Affect Disord. 2003. PMID: 14550935
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Comparison of treated and untreated major depressive disorder in a nationwide sample of Korean adults.Community Ment Health J. 2012 Jun;48(3):363-71. doi: 10.1007/s10597-011-9434-5. Epub 2011 Jun 18. Community Ment Health J. 2012. PMID: 21687981
-
SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration.PeerJ. 2014 Jun 17;2:e429. doi: 10.7717/peerj.429. eCollection 2014. PeerJ. 2014. PMID: 25024906 Free PMC article.
-
Fluvoxamine versus other anti-depressive agents for depression.Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD006114. doi: 10.1002/14651858.CD006114.pub2. Cochrane Database Syst Rev. 2010. PMID: 20238342 Free PMC article.
-
European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.Trials. 2016 Aug 3;17(1):387. doi: 10.1186/s13063-016-1511-1. Trials. 2016. PMID: 27488181 Free PMC article. Clinical Trial.
-
Future antidepressants: what is in the pipeline and what is missing?CNS Drugs. 2004;18(11):705-32. doi: 10.2165/00023210-200418110-00002. CNS Drugs. 2004. PMID: 15330686 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources